Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Treasury Shares (2017 - 2023)

Historic Treasury Shares for Dianthus Therapeutics (DNTH) over the last 5 years, with Q3 2023 value amounting to $63.0.

  • Dianthus Therapeutics' Treasury Shares changed N/A to $63.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $63.0, marking a year-over-year change of. This contributed to the annual value of $16084.0 for FY2022, which is N/A changed from last year.
  • Dianthus Therapeutics' Treasury Shares amounted to $63.0 in Q3 2023.
  • In the past 5 years, Dianthus Therapeutics' Treasury Shares registered a high of $205722.0 during Q4 2019, and its lowest value of $63.0 during Q3 2023.
  • Moreover, its 3-year median value for Treasury Shares was $16084.0 (2022), whereas its average is $73956.3.
  • Examining YoY changes over the last 5 years, Dianthus Therapeutics' Treasury Shares showed a top increase of 7988.09% in 2019 and a maximum decrease of 7988.09% in 2019.
  • Over the past 3 years, Dianthus Therapeutics' Treasury Shares (Quarter) stood at $205722.0 in 2019, then plummeted by 92.18% to $16084.0 in 2022, then plummeted by 99.61% to $63.0 in 2023.
  • Its Treasury Shares stands at $63.0 for Q3 2023, versus $16084.0 for Q4 2022 and $205722.0 for Q4 2019.